Although acute viral bronchiolitis is the most common lower respiratory tract infection in the first year of life, it has remained frustratingly resistant to treatment with drugs. Lung function tests on sedated infants in the convalescent phase have failed to demonstrate any benefit from nebulised isoprenaline, salbutamol, phenylephrine, or epinephrine.1-3 Other trials have been unable to show that antibiotics, corticosteroids, and recently, theophylline in any way influence the course of the disease. [4] [5] [6] [7] Despite this, many paediatricians continue to give bronchodilator drugs in the acute phase, claiming that results from trials carried out during convalescence cannot be extrapolated to the critical stage of the illness.
Objective measurements of lung function in the critical phase of bronchiolitis have not been possible since few infants will tolerate a face mask without sedation, and this is precluded in the presence of respiratory failure.
In order to overcome this problem, we have devised a new technique which allows us to study the total work of breathing in acutely sick infants without the need for sedation, using an inflated rubber jacket to measure tidal volume and a water-filled nasogastric tube to record oesophageal pressure. This system has been fully validated and used to collect information on the natural history of acute severe bronchiolitis.8 9 We therefore set out to study a group of babies in the critical phase of acute viral bronchiolitis to assess the therapeutic effects of 3 nebulised solutions: salbutamol, ipratropium bromide, and water, using this non-invasive technique to measure changes in total work of breathing. Salbutamol was chosen because it is widely used clinically, and because the results could be compared with previous reports of trials performed in the convalescent period.1-3
Ipratropium bromide, an anti-cholinergic drug, is an atropine derivate which has minimal effects on secretions and heart rate. It was chosen on the grounds that previous studies have shown that, unlike P2 stimulants, it is effective in relieving airways obstruction in some wheezy toddlers and babies. 10 Results for the work of breathing after the inhalations are shown in Figure 2a and b and in Table 1 , and changes in other lung function parameters in Table 2 . Although 2 infants showed a larger than 25% improvement after nebulised water, no change was seen in the group as a whole. In one who showed a >25% deterioration, work per minute was 220% of the initial reading and work per litre 282 % of initial.
After nebulised salbutamol there was effectively no change in work of breathing per litre (0.5% increase) and a mean deterioration of 21-8% in work per minute with 4 infants showing a larger than 25% change. Coughing occurred in 6 babies during the inhalation of this drug.
Ipratropium bromide however produced a mean improvement of 18-2% in work of breathing per minute with 6 babies showing a larger than 25% change. The mean 16 % fall in work of breathing per litre included 3 babies with a larger than 25 % improvement. No child had a larger than 23 % deterioration in work of breathing per minute or per litre after ipratropium bromide. This study indicates that ipratropium bromide does sometimes reduce airways obstruction in acute bronchiolitis. We are currently assessing whether 250 jig of the drug, given as a nebulised solution 6-hourly, has any effect on the natural history compared with nebulised saline.
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